Armando Santoro
IRCCS Humanitas Research Hospital
2 papers in the Anchorcite directory, published between 2004 and 2008, cited 18,319 times in total.
ORCID profileResearch topics
- Colorectal Cancer Treatments and Studies · 2 papers
- Hepatocellular Carcinoma Treatment and Prognosis · 1 paper
- Renal cell carcinoma treatment · 1 paper
- HER2/EGFR in Cancer Research · 1 paper
- Colorectal Cancer Surgical Treatments · 1 paper
Frequent co-authors
- Josep Maria Llovet · 1 paper
- Sergio Ricci · 1 paper
- Vincenzo Mazzaferro · 1 paper
- Philip a. Hilgard · 1 paper
- Edward John Gane · 1 paper
- Jean Frédéric Blanc · 1 paper
- André Cosme de Oliveira · 1 paper
- Jean‐Luc Raoul · 1 paper
Papers
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine · 2008 · 13,250 citations
BACKGROUND: No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in…
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine · 2004 · 5,069 citations
BACKGROUND: The epidermal growth factor receptor (EGFR), which participates in signaling pathways that are deregulated in cancer cells, commonly appears on colorectal-cancer cells. Cetuximab is a monoclonal antibody that specifically blocks the EGFR. We compared the efficacy of cetuximab in…
Metadata from OpenAlex (CC0).